Corbus Pharmaceuticals (CRBP) PT Lowered to $33 at Jefferies
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/31/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
Tweet
Share
E-mailGet Alerts CRBP Hot Sheet
Price: $4.22 --0%
Rating Summary:
12 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 50 | New: 9
Rating Summary:
12 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 14 | Down: 50 | New: 9
Join SI Premium – FREE
Jefferies analyst Maury Raycroft lowered the price target on Corbus Pharmaceuticals (NASDAQ: CRBP) to $33.00 (from $36.00) while maintaining a Buy rating.
You May Also Be Interested In
- Corbus Pharmaceuticals (CRBP) PT Lowered to $24 at Mizuho
- Monolithic Power Systems (MPWR) PT Raised to $1,906 at Truist Securities
- Digital Realty Trust (DLR) PT Lowered to $227 at Freedom Broker
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
